Shareholders Can Be Confident That Merck's (NYSE:MRK) Earnings Are High Quality
Merck & Co., Inc. (NYSE:MRK) reported strong earnings, but its stock price remained stable. Analysts suggest that unusual expenses of US$4.2 billion may not recur, indicating potential profit growth. Merck's earnings per share rose by 20% last year, and future profitability looks promising. However, there is one warning sign to consider. Investors are encouraged to explore further details about Merck's financial health and risks.
Explore Merck's Fair Values from the Community and select yours
Merck & Co., Inc. (NYSE:MRK) just reported healthy earnings but the stock price didn't move much. Our analysis suggests that investors might be missing some promising details.
We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free.
The Impact Of Unusual Items On Profit
To properly understand Merck's profit results, we need to consider the US$4.2b expense attributed to unusual items. While deductions due to unusual items are disappointing in the first instance, there is a silver lining. We looked at thousands of listed companies and found that unusual items are very often one-off in nature. And, after all, that's exactly what the accounting terminology implies. If Merck doesn't see those unusual expenses repeat, then all else being equal we'd expect its profit to increase over the coming year.
That might leave you wondering what analysts are forecasting in terms of future profitability. Luckily, you can click here to see an interactive graph depicting future profitability, based on their estimates.
Our Take On Merck's Profit Performance
Because unusual items detracted from Merck's earnings over the last year, you could argue that we can expect an improved result in the current quarter. Because of this, we think Merck's earnings potential is at least as good as it seems, and maybe even better! And on top of that, its earnings per share increased by 20% in the last year. Of course, we've only just scratched the surface when it comes to analysing its earnings; one could also consider margins, forecast growth, and return on investment, among other factors. If you'd like to know more about Merck as a business, it's important to be aware of any risks it's facing. While conducting our analysis, we found that Merck has 1 warning sign and it would be unwise to ignore it.
Today we've zoomed in on a single data point to better understand the nature of Merck's profit. But there is always more to discover if you are capable of focussing your mind on minutiae. For example, many people consider a high return on equity as an indication of favorable business economics, while others like to 'follow the money' and search out stocks that insiders are buying. So you may wish to see this free collection of companies boasting high return on equity, or this list of stocks with high insider ownership.
